Suppr超能文献

肺气肿患者非小细胞肺癌肺叶切除术后肺功能的改善

Improvement of pulmonary function after lobectomy for non-small cell lung cancer in emphysematous patients.

作者信息

Carretta A, Zannini P, Puglisi A, Chiesa G, Vanzulli A, Bianchi A, Fumagalli A, Bianco S

机构信息

Department of Thoracic Surgery, Scientific Institute H San Raffaele, University of Milan, Italy.

出版信息

Eur J Cardiothorac Surg. 1999 May;15(5):602-7. doi: 10.1016/s1010-7940(99)00062-7.

Abstract

OBJECTIVE

Pulmonary emphysema is frequently associated with lung cancer and, because of the impaired pulmonary function involved, it may contraindicate surgical treatment. However, improvement of pulmonary function has been observed after surgical resection in patients with advanced emphysema. The aim of this study was to evaluate whether pulmonary emphysema, as assessed by pulmonary function tests and radiological evaluation, can influence postoperative respiratory function after lobectomy for non-small cell lung cancer (NSCLC).

METHODS

Respiratory function was evaluated before and after lobectomy for NSCLC. Radiological evaluation of emphysema was performed on chest X-ray and CT scan. Patients that had undergone chemo- or radiotherapy or had segmental or lobar atelectasis were excluded from the study.

RESULTS

Thirty-five patients entered the study. A decrease in static lung volumes was observed after surgery. Total lung capacity (TLC) decreased from 6.58+/-0.92 to 5.46+/-0.77 l; functional residual capacity (FRC) from 3.70+/-0.88 to 2.96+/-0.73 1 and residual volume (RV) from 2.93+/-0.78 to 2.2+/-0.53 l. However, in a subgroup of 10 patients (Group 1), dynamic volumes after surgery were unchanged or slightly increased (forced vital capacity (FVC) from 3.23+/-0.65 to 3.3+/-0.68 l; forced expiratory volume in 1 s (FEV1) from 2.14+/-0.51 to 2.25+/-0.54 l), and airway resistances (sRaw) decreased from 15.58+/-5.18 to 11.42+/-5.25 cm H2O/s. Preoperative data showed that these patients had a greater obstruction, with FEV1 changing from 69+/-12.42 to 72.70+/-13.72% of predicted, as compared with a change from 87+/-12.7 to 72.08+/-13.10% in the other group of 25 patients (Group 2). Correlation analysis reached statistical significance between FEV1% variation (deltaFEV1%) and preoperative FEV1 and FVC% (r = -0.49, P = 0.002 and r = -0.5, P = 0.001, respectively) and between delta (FEV1)% and radiological scores for 3-level CT (r = 0.39, P = 0.04) and the sum of chest X-ray, single and 3-level CT scores (r = 0.49, P = 0.01).

CONCLUSIONS

Pulmonary function may remain unchanged or even increase after lobectomy in patients with a pronounced emphysematous component of airway obstruction. The identification of preoperative parameters that identify this group of patients could extend the indications for the treatment of lung cancer in patients with pulmonary emphysema.

摘要

目的

肺气肿常与肺癌相关,且由于涉及肺功能受损,可能成为手术治疗的禁忌证。然而,晚期肺气肿患者在手术切除后肺功能有改善。本研究旨在评估通过肺功能测试和影像学评估所确定的肺气肿是否会影响非小细胞肺癌(NSCLC)肺叶切除术后的呼吸功能。

方法

对NSCLC患者在肺叶切除术前和术后进行呼吸功能评估。通过胸部X线和CT扫描对肺气肿进行影像学评估。排除接受过化疗或放疗或有节段性或肺叶性肺不张的患者。

结果

35例患者进入研究。术后观察到静态肺容量下降。肺总量(TLC)从6.58±0.92升降至5.46±0.77升;功能残气量(FRC)从3.70±0.88升降至2.96±0.73升,残气量(RV)从2.93±0.78升降至2.2±0.53升。然而,在10例患者的亚组(第1组)中,术后动态肺容量未改变或略有增加(用力肺活量(FVC)从3.23±0.65升增至3.3±0.68升;第1秒用力呼气量(FEV1)从2.14±0.51升增至2.25±0.54升),气道阻力(sRaw)从15.58±5.18厘米水柱/秒降至11.42±5.25厘米水柱/秒。术前数据显示,与另一组25例患者(第2组)从87±12.7降至72.08±13.10%相比,这些患者阻塞更严重,FEV1从预计值的69±12.42%变为72.70±13.72%。相关性分析显示,FEV1%变化(ΔFEV1%)与术前FEV1和FVC%之间(分别为r = -0.49,P = 0.002和r = -0.5,P = 0.001)以及Δ(FEV1)%与3级CT的影像学评分之间(r = 0.39,P = 0.04)和胸部X线、单层和3级CT评分总和之间(r = 0.49,P = 0.01)均具有统计学意义。

结论

气道阻塞性肺气肿成分明显的患者肺叶切除术后肺功能可能保持不变甚至改善。识别术前可确定这类患者的参数可能会扩大肺气肿患者肺癌治疗的适应证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验